TABLE OF CONTENTS
|  | | | Volume 50, Issue 1 (January 2015) |  | In this issue
 Editorial
Reviews
Special Report
Original Articles
Letter to the Editor
Also new
   AOP | | | | Editorial | Top | | Gynecologic care after hematopoietic cell transplantation: a call to action to include gynecologists in the transplant team P Stratton Bone Marrow Transplant 2015 50: 1-2; advance online publication, November 3, 2014; 10.1038/bmt.2014.247 Full Text | | Reviews | Top | | Clinical guidelines for gynecologic care after hematopoietic SCT. Report from the international consensus project on clinical practice in chronic GVHD B Frey Tirri, P Häusermann, H Bertz, H Greinix, A Lawitschka, C-P Schwarze, D Wolff, J P Halter, D Dörfler and R Moffat Bone Marrow Transplant 2015 50: 3-9; advance online publication, October 27, 2014; 10.1038/bmt.2014.242 Abstract | Full Text | | Is ‘informed consent’ an ‘understood consent’ in hematopoietic cell transplantation? A D’Souza, M Pasquini and R Spellecy Bone Marrow Transplant 2015 50: 10-14; advance online publication, September 22, 2014; 10.1038/bmt.2014.207 Abstract | Full Text | | Special Report | Top | | Children as hematopoietic cell donors in research: when is it approvable? N N Shah, A S Wayne, C Grady, T Fry and D Wendler Bone Marrow Transplant 2015 50: 15-19; advance online publication, October 20, 2014; 10.1038/bmt.2014.224 Abstract | Full Text | | Original Articles | Top | | ACUTE LEUKEMIA | Haploidentical hematopoietic SCT may be superior to conventional consolidation/maintenance chemotherapy as post-remission therapy for high-risk adult ALL Y-q Sun, J Wang, Q Jiang, L-p Xu, D-h Liu, X-h Zhang, K-y Liu and X-j Huang Bone Marrow Transplant 2015 50: 20-25; advance online publication, September 15, 2014; 10.1038/bmt.2014.195 Abstract | Full Text | | Real-time assessment of relapse risk based on the WT1 marker in acute leukemia and myelodysplastic syndrome patients after hematopoietic cell transplantation A Israyelyan, L Goldstein, W Tsai, L Aquino, S J Forman, R Nakamura and D J Diamond Bone Marrow Transplant 2015 50: 26-33; advance online publication, September 22, 2014; 10.1038/bmt.2014.209 Abstract | Full Text | | HEMATOPOIETIC CELL COLLECTION | Plerixafor in patients with lymphoma and multiple myeloma: effectiveness in cases with very low circulating CD34+ cell levels and preemptive intervention vs remobilization I Sánchez-Ortega, S Querol, M Encuentra, S Ortega, A Serra, J M Sanchez-Villegas, J R Grifols, M M Pujol-Balaguer, M Pujol-Bosch, J M Martí, T Garcia-Cerecedo, P Barba, J M Sancho, A Esquirol, J Sierra and R F Duarte Bone Marrow Transplant 2015 50: 34-39; advance online publication, September 15, 2014; 10.1038/bmt.2014.196 Abstract | Full Text | | GRAFT SOURCE | Delayed hematopoietic recovery after auto-SCT in patients receiving arsenic trioxide-based therapy for acute promyelocytic leukemia: a multi-center analysis G N Mannis, A C Logan, A D Leavitt, M Yanada, J Hwang, R L Olin, L E Damon, C Andreadis, W Z Ai, K M Gaensler, C C Greene, N K Gupta, L D Kaplan, A Mahindra, Y Miyazaki, T Naoe, S Ohtake, P H Sayre, C C Smith, J M Venstrom, J L Wolf, L Caballero, N Emi and T G Martin Bone Marrow Transplant 2015 50: 40-44; advance online publication, September 22, 2014; 10.1038/bmt.2014.201 Abstract | Full Text | | Impact of rabbit ATG-containing myeloablative conditioning regimens on the outcome of patients undergoing unrelated single-unit cord blood transplantation for hematological malignancies L Pascal, M Mohty, A Ruggeri, L Tucunduva, N Milpied, P Chevallier, R Tabrizi, M Labalette, E Gluckman, M Labopin and I Yakoub-Agha Bone Marrow Transplant 2015 50: 45-50; advance online publication, October 20, 2014; 10.1038/bmt.2014.216 Abstract | Full Text | | CELLULAR THERAPY | Adoptive therapy with donor lymphocyte infusion after allogenic hematopoietic SCT in pediatric patients J Gozdzik, K Rewucka, A Krasowska-Kwiecien, A Pieczonka, R Debski, A Zaucha-Prazmo, K Drabko, J Krukowska-Jaros, M Wozniak, J Kowalczyk, M Wysocki, E Gorczynska, K Kalwak, A Chybicka and J Wachowiak on behalf of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation (PPGHSCT) Bone Marrow Transplant 2015 50: 51-55; advance online publication, October 13, 2014; 10.1038/bmt.2014.200 Abstract | Full Text | | | | DLI after haploidentical BMT with post-transplant CY A Ghiso, A M Raiola, F Gualandi, A Dominietto, R Varaldo, M T Van Lint, S Bregante, C Di Grazia, T Lamparelli, F Galaverna, A Stasia, S Luchetti, S Geroldi, R Grasso, N Colombo and A Bacigalupo Bone Marrow Transplant 2015 50: 56-61; advance online publication, October 13, 2014; 10.1038/bmt.2014.217 Abstract | Full Text | | | | A multicentre UK study of GVHD following DLI: Rates of GVHD are high but mortality from GVHD is infrequent J J Scarisbrick, F L Dignan, S Tulpule, E D Gupta, S Kolade, B Shaw, F Evison, G Shah, E Tholouli, G Mufti, A Pagliuca, R Malladi and K Raj Bone Marrow Transplant 2015 50: 62-67; advance online publication, October 13, 2014; 10.1038/bmt.2014.227 Abstract | Full Text | | GRAFT MANIPULATION | Impact of CD34+ cell dose in children who receive unrelated PBSCT with in vivo T-cell depletion for hematologic malignancies J W Lee, S-k Kim, P-S Jang, N-G Chung, D-C Jeong, B Cho and H-K Kim Bone Marrow Transplant 2015 50: 68-73; advance online publication, September 29, 2014; 10.1038/bmt.2014.202 Abstract | Full Text | | CONDITIONING | Equivalent outcomes using reduced intensity or conventional myeloablative conditioning transplantation for patients aged 35 years and over with AML M Sébert, R Porcher, M Robin, L Adès, N Boissel, E Raffoux, A Xhaard, N Dhedin, J Larghero, C Himberlin, A Delmer, P Fenaux, H Dombret, G Socié and R P de Latour Bone Marrow Transplant 2015 50: 74-81; advance online publication, September 22, 2014; 10.1038/bmt.2014.199 Abstract | Full Text | | Impact of pre-transplant co-morbidities on outcome after alemtuzumab-based reduced intensity conditioning allo-SCT in elderly patients: A British Society of Blood and Marrow Transplantation study E Nikolousis, S Nagra, R Pearce, J Perry, K Kirkland, J Byrne, F Dignan, E Tholouli, M Gilleece, N Russell, T Littlewood, M Cook, A Peniket, B E Shaw, G Cook and C Craddock Bone Marrow Transplant 2015 50: 82-86; advance online publication, October 6, 2014; 10.1038/bmt.2014.215 Abstract | Full Text | | TRANSPLANT TOXICITIES | The impact of center accreditation on hematopoietic cell transplantation (HCT) S Marmor, J W Begun, J Abraham and B A Virnig Bone Marrow Transplant 2015 50: 87-94; advance online publication, November 10, 2014; 10.1038/bmt.2014.219 Abstract | Full Text | | Efficacy, toxicity and mortality of autologous SCT in multiple myeloma patients with dialysis-dependent renal failure R St Bernard, L Chodirker, E Masih-Khan, H Jiang, N Franke, V Kukreti, R Tiedemann, S Trudel, D Reece and C I Chen Bone Marrow Transplant 2015 50: 95-99; advance online publication, October 6, 2014; 10.1038/bmt.2014.226 Abstract | Full Text | | Severe weight loss in 3 months after allogeneic hematopoietic SCT was associated with an increased risk of subsequent non-relapse mortality S Fuji, T Mori, N Khattry, J Cheng, Y R Do, K Yakushijin, S Kohashi, T Fukuda and S-W Kim on behalf of the Nutritional Support Working Group of the Asian Pacific Bone Marrow Transplantation Bone Marrow Transplant 2015 50: 100-105; advance online publication, October 6, 2014; 10.1038/bmt.2014.228 Abstract | Full Text | | GRAFT-VERSUS-HOST DISEASE | Low-dose antithymocyte globulin enhanced the efficacy of tacrolimus and mycophenolate for GVHD prophylaxis in recipients of unrelated SCT V Ratanatharathorn, A Deol, L Ayash, S Cronin, D Bhutani, L G Lum, M Abidi, M Ventimiglia, K Mellert and J P Uberti Bone Marrow Transplant 2015 50: 106-112; advance online publication, October 6, 2014; 10.1038/bmt.2014.203 Abstract | Full Text | | Thrombomodulin alleviates murine GVHD in association with an increase in the proportion of regulatory T cells in the spleen T Ikezoe, J Yang, C Nishioka and A Yokoyama Bone Marrow Transplant 2015 50: 113-120; advance online publication, September 22, 2014; 10.1038/bmt.2014.208 Abstract | Full Text | | GVHD prophylaxis with sirolimus-tacrolimus may overcome the deleterious effect on survival of HLA mismatch after reduced-intensity conditioning allo-SCT R Parody, L Lopez-Corral, O L Godino, I G Cadenas, A P Martinez, L Vazquez, R Martino, C Martinez, C Solano, P Barba, D Valcarcel, T Caballero-Velazquez, F J Marquez-Malaver, J Sierra, D Caballero and J A Perez-Simón Bone Marrow Transplant 2015 50: 121-126; advance online publication, October 13, 2014; 10.1038/bmt.2014.220 Abstract | Full Text | | Chronic GVHD induced GVL effect after unmanipulated haploidentical hematopoietic SCT for AML and myelodysplastic syndrome X-D Mo, L-P Xu, X-H Zhang, D-H Liu, Y Wang, H Chen, C-H Yan, Y-H Chen, W Han, F-R Wang, J-Z Wang, K-Y Liu and X-J Huang Bone Marrow Transplant 2015 50: 127-133; advance online publication, November 10, 2014; 10.1038/bmt.2014.223 Abstract | Full Text | | Letter to the Editor | Top | | Retrospective comparison of allogeneic vs autologous transplantation for diffuse large B-cell lymphoma with early relapse or primary induction failure A Ghobadi, E Nolley, J Liu, A McBride, K Stockerl-Goldstein and A Cashen Bone Marrow Transplant 2015 50: 134-136; advance online publication, September 22, 2014; 10.1038/bmt.2014.198 Full Text | | Persistence of high-level (1,3)-β-D-glucan after candidemia following autologous peripheral SCT in a pediatric patient A Naselli, M Faraci, E Lanino, G Morreale, G Cangemi, R Bandettini and E Castagnola Bone Marrow Transplant 2015 50: 137-138; advance online publication, September 22, 2014; 10.1038/bmt.2014.206 Full Text | | | | Sclerodermatous chronic GVHD in patients receiving tyrosine kinase inhibitors after allogeneic hematopoietic cell transplantation A Salhotra, N Tsai, S H Thomas, T Paris, P Parker, S J Forman and R Nakamura Bone Marrow Transplant 2015 50: 139-141; advance online publication, September 29, 2014; 10.1038/bmt.2014.210 Full Text | | Pretransplantation fluorine-18-deoxyglucose-positron emission tomography scan has no influence on relapse and survival in non-Hodgkin lymphoma patients undergoing allo-SCT V Bachanova, Q Cao, C Ustun, A T K Kendi, J Froelich, A Lazaryan and L J Burns Bone Marrow Transplant 2015 50: 142-144; advance online publication, September 29, 2014; 10.1038/bmt.2014.211 Full Text | | Fecal microbiota transplant after hematopoietic SCT: report of a successful case C G de Castro, Jr, A J Ganc, R L Ganc, M S Petrolli and N Hamerschlack Bone Marrow Transplant 2015 50: 145; advance online publication, September 29, 2014; 10.1038/bmt.2014.212 Full Text | | Serum immunoglobulin free light chains and post-transplant lymphoproliferative disorder among allogeneic hematopoietic stem cell transplant recipients E A Engels, O Landgren, R Costello, D Burton, S Mailankody and J Storek Bone Marrow Transplant 2015 50: 146-147; advance online publication, September 29, 2014; 10.1038/bmt.2014.213 Full Text | | Nasal GVHD N Randall, H Boyer, P J Martin, D Weisdorf, L J Burns and C Ustun Bone Marrow Transplant 2015 50: 148-149; advance online publication, September 29, 2014; 10.1038/bmt.2014.214 Full Text | | | | KIR and HLA genotypes have no identifiable role in single-unit dominance following double-unit umbilical cord blood transplantation N Tarek, M M Gallagher, J F Chou, M N Lubin, G Heller, J N Barker and K C Hsu Bone Marrow Transplant 2015 50: 150-152; advance online publication, October 13, 2014; 10.1038/bmt.2014.218 Full Text | | | | Severe chronic psychosis after allogeneic SCT from a schizophrenic sibling OPEN I E Sommer, D W van Bekkum, H Klein, R Yolken, Lot de Witte and G Talamo Bone Marrow Transplant 2015 50: 153-154; advance online publication, October 6, 2014; 10.1038/bmt.2014.221 Full Text | | Haploidentical hematopoietic SCT for acquired severe aplastic anemia using post-transplant high-dose CY N Gupta, D Choudhary, S K Sharma, V Khandelwal and M Dhamija Bone Marrow Transplant 2015 50: 155-156; advance online publication, October 6, 2014; 10.1038/bmt.2014.222 Full Text | | | | Bisphosphonates do not delay engraftment after autologous SCT in patients with newly diagnosed myeloma M J Oksman, M Itälä-Remes, M Kauppila, M Putkonen, U Salmenniemi, T Salmi and K Remes Bone Marrow Transplant 2015 50: 157; advance online publication, October 13, 2014; 10.1038/bmt.2014.225 Full Text | | Development of echinocandin resistance in Candida krusei isolates following exposure to micafungin and caspofungin in a BM transplant unit E Tavernier, M Desnos-Ollivier, F Honeyman, M Srour, A Fayard, J Cornillon, K Augeul-Meunier, D Guyotat and H Raberin Bone Marrow Transplant 2015 50: 158-160; advance online publication, November 17, 2014; 10.1038/bmt.2014.230 Full Text | | | | |  | | | | | | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com | | | | | | | | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |  | | | | |
No comments:
Post a Comment
Keep a civil tongue.